Junjun Yan
Nanjing Medical University
3 Papers
Junjun Yan is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
Zhi Wei Li,Beicheng Sun,Ting Gong,Sheng Guo,Sheng Guo,Jianhua Zhang,Jianhua Zhang,Junlong Wang,Atsushi Sugawara,Meisheng Jiang,Junjun Yan,Alexandra Gurary,Xin Zheng,Bifeng Gao,Shu-Yuan Xiao,Shu-Yuan Xiao,Wenlian Chen,Chi Ma,Christine Farrar,Chenjun Zhu,Owen T.M. Chan,Can Xin,Andrew Winnicki,John Winnicki,Mingxin Tang,Ryan Park,Mary Winnicki,Katrina Diener,Zhanwei Wang,Qicai Liu,Qicai Liu,Catherine H. Chu,Zhaohui L. Arter,Peibin Yue,Lindsay Alpert,George Hui,Peiwen Fei,James Turkson,Wentian Yang,Guangyu Wu,Ailin Tao,Joe W. Ramos,Stefan Moisyadi,Randall F. Holcombe,Wei Jia,Lutz Birnbaumer,Lutz Birnbaumer,Xiqiao Zhou,Wen-Ming Chu,Wen-Ming Chu +49 more
TL;DR: Development of increased tumors in DKO mice was not associated with changes in fecal microbiomes but was associated with activation of nuclear factor (NF) κB and signal transducer and activator of transcription (STAT3) 3; increased levels of GNAI2, nitric oxide synthase 2, and IL6; increased numbers of CD4+ DCs and MDSCs; and decreased numbers ofCD8- DCs.
72
AI-empowered integrative structural characterization of m6A methyltransferase complex
Xu Wei Yan,Kai Pei,Zeyuan Guan,Feiqing Liu,Junjun Yan,Xiaohuan Jin,Qiang Wang,Mengjun Hou,Chun Tang,Ping Yin +9 more
TL;DR: The cryogenic electron microscopy structure of human WTAP – VIRMA and a structure of the quaternary M – M – W – V complex based on AlphaFold2 predictions and structural restraints from intermolecular chemical crosslinking mass spectrometry are modeled.
Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study
TL;DR: A novel mechanism by which S1P inhibited tumour cell migration and invasion via a S1 PR2-dependent pathway is revealed, suggesting that S1PR2 may be a therapeutic target for treatment of colon cancer.